Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
August 29, 2024
Three Years On: The Role of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) since Its Initial Approval
Regina Horneff, Barbara Czech, Michael Yeh, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors
Peter Hillmen, Regina Horneff, Michael Yeh, et al.
Mitochondrion
|
January 29, 2018
Phosphorylation of the outer membrane mitochondrial protein OM64 influences protein import into mitochondria
Catharina Nickel, Regina Horneff, Ralf Heermann, et al.
Research and Practice in Thrombosis and Haemostasis
|
May 30, 2024
Thrombosis and meningococcal infection rates in pegcetacoplan-treated patients with paroxysmal nocturnal hemoglobinuria in the clinical trial and postmarketing settings
Richard J Kelly, Hisakazu Nishimori, Regina Horneff, et al.
European Journal of Haematology
|
March 25, 2023
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data
Jens Panse, Koo Wilson, Jesse Fishman, et al.
International Journal of Molecular Sciences
|
August 29, 2024
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function
Jeff Szer, Jens Panse, Austin Kulasekararaj, et al.
Blood Advances
|
April 9, 2024
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, et al.
Blood Advances
|
February 5, 2024
Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH
Morag Griffin, Richard J Kelly, Jens Panse, et al.
Nephron
|
September 19, 2025
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review
Fernando Caravaca-Fontán, Fadi Fakhouri, Matthew C Pickering, et al.
European Journal of Haematology
|
November 23, 2023
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivity
Koo Wilson, Carly Rich, Zalmai Hakimi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
August 29, 2024
Three Years On: The Role of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) since Its Initial Approval
Regina Horneff, Barbara Czech, Michael Yeh, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors
Peter Hillmen, Regina Horneff, Michael Yeh, et al.
Mitochondrion
|
January 29, 2018
Phosphorylation of the outer membrane mitochondrial protein OM64 influences protein import into mitochondria
Catharina Nickel, Regina Horneff, Ralf Heermann, et al.
Research and Practice in Thrombosis and Haemostasis
|
May 30, 2024
Thrombosis and meningococcal infection rates in pegcetacoplan-treated patients with paroxysmal nocturnal hemoglobinuria in the clinical trial and postmarketing settings
Richard J Kelly, Hisakazu Nishimori, Regina Horneff, et al.
European Journal of Haematology
|
March 25, 2023
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data
Jens Panse, Koo Wilson, Jesse Fishman, et al.
International Journal of Molecular Sciences
|
August 29, 2024
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function
Jeff Szer, Jens Panse, Austin Kulasekararaj, et al.
Blood Advances
|
April 9, 2024
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, et al.
Blood Advances
|
February 5, 2024
Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH
Morag Griffin, Richard J Kelly, Jens Panse, et al.
Nephron
|
September 19, 2025
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review
Fernando Caravaca-Fontán, Fadi Fakhouri, Matthew C Pickering, et al.
European Journal of Haematology
|
November 23, 2023
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivity
Koo Wilson, Carly Rich, Zalmai Hakimi, et al.
Page
of 2